US pauses plan to give virus vaccine to Guantanamo prisoners

The U.S. is backing off for now on a plan to offer COVID-19 vaccinations to the 40 prisoners held at the detention center at Guantanamo Bay, Cuba

Via AP news wire
Saturday 30 January 2021 22:33
Virus Outbreak-Guantanamo
Virus Outbreak-Guantanamo

The U.S. is backing off for now on a plan to offer COVID-19 vaccinations to the 40 prisoners held at the detention center at Guantanamo Bay, Cuba.

Pentagon chief spokesman John Kirby said in a tweet Saturday that the Defense Department would be “pausing” the plan to give the vaccination to those held at Guantanamo while it reviews measures to protect troops who work there.

Kirby said no prisoners had yet received the vaccination. The plan drew some criticism after The New York Times reported that the vaccination of prisoners would start in the coming days.

“We’re pausing the plan to move forward, as we review force protection protocols,” Kirby said. “We remain committed to our obligations to keep our troops safe.”

The U.S. military announced earlier this month that it planned to offer the vaccine to prisoners as it vaccinated all personnel at the detention center.

At the time, U.S. Southern Command said it expected to have enough vaccine for all of the approximately 1,500 personnel assigned to the detention center. It said that the vaccine would be offered to prisoners but did not plan to reveal how many actually received it because of medical privacy regulations.

The U.S. opened the detention center in January 2002 to hold detainees suspected of links to al-Qaida and the Taliban. Those who remain include five men facing a trial by military commission for their alleged roles planning and aiding the Sept. 11, 2001, attacks.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in